Deep Track Capital, LP
CIK 1856083 · Holdings on Dec 31, 2025 · First reported Feb 13, 2026
Top ten holdings
Q4 2025- IMVT6.68%
- GH6.52%
- GPCR6.52%
- TARS5.61%
- DVAX5.52%
- CYTK4.84%
- AXSM4.79%
- APLS4.44%
- PCVX4.21%
- MAZE4.01%
Share classes counted separately53.14%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- IONSWeight decreased · -3.88 pp6.95% → 3.07%Shares -2.11M (-55.36%)
- GPCRWeight increased · +3.23 pp3.29% → 6.52%Shares -104.03K (-2.47%)
- BMRNWeight increased · +3.08 pp0.04% → 3.12%Shares +2.28M (+9153.30%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 28
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | IMVTIMMUNOVANT INC View history and evidence | $293.02M | 6.68% | 11.53M shares | 4.38% → 6.68%+2.30 pp +1.80M (+18.48%) | Added | ↗▾ |
| 02 | GHGUARDANT HEALTH INC View history and evidence | $285.99M | 6.52% | 2.80M shares | 7.24% → 6.52%-0.72 pp -1.35M (-32.60%) | Reduced | ↗▾ |
| 03 | GPCRSTRUCTURE THERAPEUTICS INCSPONSORED ADS View history and evidence | $285.97M | 6.52% | 4.11M shares | 3.29% → 6.52%+3.23 pp -104.03K (-2.47%) | Reduced | ↗▾ |
| 04 | TARSTARSUS PHARMACEUTICALS INC View history and evidence | $245.97M | 5.61% | 3.00M shares | 4.98% → 5.61%+0.63 pp +4.03K (+0.13%) | Added | ↗▾ |
| 05 | DVAXDYNAVAX TECHNOLOGIES CORPCOM NEW View history and evidence | $241.87M | 5.52% | 15.73M shares | 4.36% → 5.52%+1.16 pp 0 (0.00%) | Unchanged | ↗▾ |
| 06 | CYTKCYTOKINETICS INCCOM NEW View history and evidence | $212.03M | 4.84% | 3.34M shares | 6.60% → 4.84%-1.76 pp -963.00K (-22.40%) | Reduced | ↗▾ |
| 07 | AXSMAXSOME THERAPEUTICS INC View history and evidence | $210.04M | 4.79% | 1.15M shares | 3.05% → 4.79%+1.74 pp +250.00K (+27.78%) | Added | ↗▾ |
| 08 | APLSAPELLIS PHARMACEUTICALS INC View history and evidence | $194.68M | 4.44% | 7.75M shares | 5.05% → 4.44%-0.61 pp -250.38K (-3.13%) | Reduced | ↗▾ |
| 09 | PCVXVAXCYTE INC View history and evidence | $184.56M | 4.21% | 4.00M shares | 3.02% → 4.21%+1.19 pp +1.00M (+33.33%) | Added | ↗▾ |
| 10 | MAZEMAZE THERAPEUTICS INC View history and evidence | $175.93M | 4.01% | 4.25M shares | 2.86% → 4.01%+1.15 pp +297.53K (+7.53%) | Added | ↗▾ |
Options overlay 2
$1.22B notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
XBISS SPDR S&P BIOTECH ETFSTATE STREET SPD View history and evidence | Put | 10.00M | $1.22B | +10.00M | ▾ |
BHVNBIOHAVEN LTD View history and evidence | Call | 500.00K | $5.64M | +500.00K | ▾ |
2 / 2 options · preview only
Exited positions 18
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| AKRO AKERO THERAPEUTICS INC | Non-derivative | -4,000,978 | -$189.97M | SEC filing ↗ | SEC filing ↗ |
| ETNB 89BIO INC | Non-derivative | -9,356,171 | -$137.54M | SEC filing ↗ | SEC filing ↗ |
| PTGX PROTAGONIST THERAPEUTICS INC | Non-derivative | -1,715,691 | -$113.97M | SEC filing ↗ | SEC filing ↗ |
3 / 18 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1856083 · Period 2025-12-31
Data loaded 2026-09-23 · First reported 2026-02-13
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 5608747587
}Research all 55 reported holdings.
This page includes 30 of 55 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 55 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1856083","quarter":"2025Q4","page_size":100}
get_institutional_manager_history
{"cik":"1856083","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.